GlassScriptPhysician profile
Sharon S Harig
NPI 1770585861
$2,096.84
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $211 · 2021: $1,137 · 2022: $296.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $565.66 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $298.28 | 2019-2022 | |
| Mylan Specialty L.P. | $226.95 | 2019-2022 | |
| Pfizer INC. | $174.41 | 2019-2021 | |
| Genzyme Corporation | $150.93 | 2019-2021 | |
| Genentech USA, INC. | $125.00 | 2019 | |
| Ekos Corporation | $93.33 | 2019 | |
| Glaxosmithkline, LLC. | $92.57 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $83.68 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $57.23 | 2021 | |
| Advanced Respiratory, INC | $43.39 | 2019-2021 | |
| United Therapeutics Corporation | $31.35 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.96 | 2021 | |
| Jazz Pharmaceuticals INC. | $23.04 | 2022 | |
| Shionogi INC | $22.05 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $18.14 | 2019 | |
| Circassia INC. | $14.93 | 2019 | |
| Merck Sharp & Dohme LLC | $14.35 | 2021 | |
| Insmed, INC. | $13.58 | 2019 | |
| Philips North America LLC | $12.33 | 2019 | |
| Abbvie INC. | $11.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Harig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.